Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan 8;16(2):270.
doi: 10.3390/cancers16020270.

MR-LINAC, a New Partner in Radiation Oncology: Current Landscape

Affiliations
Review

MR-LINAC, a New Partner in Radiation Oncology: Current Landscape

Abrahams Ocanto et al. Cancers (Basel). .

Abstract

Technological advances in radiation oncology are oriented towards improving treatment precision and tumor control. Among these advances, magnetic-resonance-image-guided radiation therapy (MRgRT) stands out, with technological advances to deliver targeted treatments adapted to a tumor's anatomy on the day while minimizing incidental exposure to organs at risk, offering an unprecedented therapeutic advantage compared to X-ray-based IGRT delivery systems. This new technology changes the traditional workflow in radiation oncology and requires an evolution in team coordination to administer more precise treatments. Once implemented, it paves the way for newer indication for radiation therapy to safely deliver higher doses than ever before, with better preservation of healthy tissues to optimize patient outcomes. In this narrative review, we assess the technical aspects of the novel linear accelerators that can deliver MRgRT and summarize the available published experience to date, focusing on oncological results and future challenges.

Keywords: adaptative radiotherapy; image guidance; radiotherapy; stereotactic body radiotherapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
MR-LINAC prostate cancer treatment. Red line: Prostate. Yellow line: Margins of 2mm (A) Gating during SBRT, (B) Displacement of gland by intestinal gas.
Figure 2
Figure 2
MR-LINAC Liver metastases treatment. Red line: Liver Metastases. Yellow line: Margins of 3 mm (A) Gating during SBRT, (B) Displacement of tumor during respiration.
Figure 3
Figure 3
MR-LINAC Pancreatic cancer treatment. Red line: Pancreatic tumor. Yellow line: Margins of 3 mm (A) Gating during SBRT, (B) Displacement of tumor during respiration.
Figure 4
Figure 4
MR-LINAC of two metastases of lung cancer in adrenal glands. Red line: Adrenal glands with tumor. Yellow line: Margins of 3 mm (A) Gating during SBRT, (B) Displacement of two tumors during respiration.

References

    1. Friedland G.W., Thurber B.D., Thurber G.W.F.A.B.D., Christner J.A., Kofler J.M., McCollough C.H., Johnson T.R.C., Donnelly L.F., Emery K.H., Brody A.S., et al. The birth of CT. Am. J. Roentgenol. 1996;167:1365–1370. doi: 10.2214/ajr.167.6.8956560. - DOI - PubMed
    1. Klopp A.H., Yeung A.R., Deshmukh S., Gil K.M., Wenzel L., Westin S.N., Gifford K., Gaffney D.K., Small W., Thompson S., et al. Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology–RTOG 1203. J. Clin. Oncol. 2018;36:2538–2544. doi: 10.1200/JCO.2017.77.4273. - DOI - PMC - PubMed
    1. Yan D., Vicini F., Wong J., Martinez A. Adaptive radiation therapy. Phys. Med. Biol. 1997;42:123–132. doi: 10.1088/0031-9155/42/1/008. - DOI - PubMed
    1. Waksman Minsky N., Saucedo Yáñez A. Breve historia de la Resonancia Magnética Nuclear: Desde el descubrimiento hasta la aplicación en imagenología. Educ. Quím. 2019;30:129. doi: 10.22201/fq.18708404e.2019.2.68418. - DOI
    1. Potters L., Kavanagh B., Galvin J.M., Hevezi J.M., Janjan N.A., Larson D.A., Mehta M.P., Ryu S., Steinberg M., Timmerman R., et al. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guideline for the Performance of Stereotactic Body Radiation Therapy. Int. J. Radiat. Oncol. Biol. Phys. 2010;76:326–332. doi: 10.1016/j.ijrobp.2009.09.042. - DOI - PubMed